Brind.

Plus Therapeutics is receiving funding from the Cancer Prevention and Research Institute of Texas for a dose optimization trial.

2 reports, 1 independent Updated Jul 23
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Plus Therapeutics is receiving funding from the Cancer Prevention and Research Institute of Texas for a dose optimization trial.

Who's involved

What this event is mainly about
Plus TherapeuticsCancer Prevention and Research Institute of Texas

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswirePlus Therapeutics Announces $1.6 Million Advance Payment from CPRIT Payment is part of $17.6 million award granted for leptomeningeal cancer targeted radiotherapeutic development program HOUSTON, Jul
  • Unknown outlet